Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway

Background: Silibinin is widely utilized drug in various cancer treatments, though its application in cholangiocarcinoma has not yet been explored. For the first time, we evaluated the anticancer potential and underlying molecular mechanism of silibinin in treatment of cholangiocarcinoma treatment.M...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Bai (Author), Jiaqi Chen (Author), Weijian Hu (Author), Lei Wang (Author), Yulian Wu (Author), Shi'an Yu (Author)
Format: Book
Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available